Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
NantWorks GPS Cancer, also known as Precision Omics Profiling, is a type of advanced laboratory test that looks deeply into the biology of a cancer tumor. It uses methods like genomics (studying the tumor’s DNA), transcriptomics (studying gene activity), and proteomics (studying proteins) to gather detailed information about the tumor’s unique characteristics. This information helps doctors understand how the cancer might behave and which treatments could be most effective.
Understanding the specific features of a tumor can help personalize cancer treatment. Instead of using a one-size-fits-all approach, precision profiling like NantWorks GPS Cancer aims to tailor treatment based on the tumor’s biology. This can sometimes identify targeted therapies or clinical trials that might be more suitable. However, it is important to remember that not all test results lead to proven treatment options, and the science is still evolving.
Patients may encounter this term in their medical records, pathology reports, or during discussions with their care team. It might be mentioned when doctors talk about personalized or precision medicine approaches. Sometimes, it may also appear in research or clinical trial information. Patients might hear it described as a way to better understand their cancer or to help guide treatment decisions.
This test is not a treatment or cure. It does not guarantee that a specific therapy will work or that the cancer will respond. Some results may be exploratory or not yet clinically actionable. It is important not to overinterpret the findings or assume that the test replaces standard treatments. It is a tool to support decision-making, not a standalone solution.
Oncologists may use NantWorks GPS Cancer results to help decide on treatment plans, especially when standard options are limited or when considering targeted therapies. The test can provide insights during diagnosis, staging, or follow-up. However, doctors will interpret the results in the context of the patient’s overall health, cancer type, and other test findings.
Because the name and concept can be complex, patients might confuse this test with treatments or expect immediate benefits. It’s helpful to ask your care team what the test results mean for your specific case, how they influence your treatment options, and whether the findings are actionable. Also, clarify if the test is part of standard care or an additional option you are considering.
While the test itself is generally safe as it involves analyzing tumor samples, risks include misunderstanding results or pursuing unproven treatments based on findings. Patients should discuss the test and its implications thoroughly with their oncology team, who understand their diagnosis, current treatments, and goals of care. This ensures decisions are made within a safe and evidence-based context.
If NantWorks GPS Cancer or Precision Omics Profiling is mentioned in your care, the best next step is to ask your healthcare providers to explain what the test results mean for you personally. Understanding how this information fits into your overall treatment plan can help you make informed choices and avoid confusion. Remember, this test is one part of a larger picture in cancer care.